This post was originally published on this site
Myles O’Neill, senior vice president and president of Lilly’s manufacturing operations, will retire in early May, after nearly two decades with the company, Lilly said.
O’Neill, 62, will be replaced by Edgardo Hernandez, who is currently senior vice president of the drugmaker’s global injectible drug product and device manufacturing division.
The drugmaker also said Chief Ethics and Compliance Officer Melissa Barnes will retire in June.
Barnes, 52, has been with the company for 26 years and will be replaced by Lilly Deputy General Counsel Alonzo Weems.
